Lindsay Wilde, MD

NPI 1063701316ActiveIndividual· Internal Medicine, Medical Oncology· Philadelphia, PA

Internal Medicine, Medical Oncology (MD) in Philadelphia, Pennsylvania, trained at Jefferson Medical College of Thomas Jefferson University (class of 2011). Their prescriptions cost Medicare Part D more than their services did: $765,265 for 163 claims, against $29,619 paid for services in 2024. Astrazeneca Pharmaceuticals LP reported $43.25 in payments in 2025, mostly education.

Overview

NPI	1063701316
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Apr 6, 2011
Last updated in NPPES	Aug 22, 2018

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Medical Oncology Primary	207RX0202X	MD451786	PA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Internal Medicine (PA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	98
Services billed	319 across 14 procedure codes
Paid by Medicare	$29,619

Part D prescriptions in 2024

Prescriptions (claims)	163 · 221 30-day fills
Patients	36
Total drug cost	$765,265
Generic share	67% of claims

Medicare sources and data years

Education and affiliations

Medical school	Jefferson Medical College of Thomas Jefferson University
Graduation year	2011
Medicare specialty	Internal Medicine
Telehealth	Offers telehealth